Colin Hislop

2010 - Anthera Pharmaceuticals

In 2010, Colin Hislop earned a total compensation of $649.7K as Chief Medical Officer at Anthera Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$132,000
Salary$303,333
Stock Awards$214,400
Total$649,733

Hislop received $303.3K in salary, accounting for 47% of the total pay in 2010.

Hislop also received $132K in non-equity incentive plan and $214.4K in stock awards.

Rankings

In 2010, Colin Hislop's compensation ranked 6,807th out of 10,439 executives tracked by ExecPay. In other words, Hislop earned more than 34.8% of executives.

ClassificationRankingPercentile
All
6,807
out of 10,439
35th
Division
Manufacturing
2,478
out of 3,838
35th
Major group
Chemicals And Allied Products
572
out of 921
38th
Industry group
Drugs
374
out of 680
45th
Industry
Pharmaceutical Preparations
283
out of 481
41st
Source: SEC filing on April 5, 2013.

Hislop's colleagues

We found four more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2010.

2010

Paul Truex

Anthera Pharmaceuticals

Chief Executive Officer

2010

Christopher Lowe

Anthera Pharmaceuticals

Chief Financial Officer

2010

Debra Odink

Anthera Pharmaceuticals

Chief Technology Officer

2010

Georgina Kilfoil

Anthera Pharmaceuticals

Senior Vice President, Product Development

You may also like